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Abstract
In vitro testing can contribute to reduce the risk that the use of genetically modified (GM) crops and their proteins show
unintended toxic effects. Here we introduce a porcine intestinal cell culture (IPEC-J2) as appropriate in vitro model and
tested the possible toxic potential of Cry1Ab protein, commonly expressed in GM-maize. For comprehensive risk
assessment we used WST-1 conversion and ATP content as metabolic markers for proliferation, lactate dehydrogenase
release as indicator for cells with compromised membrane and transepithelial electrical resistance as parameter indicating
membrane barrier function. The results were compared to the effects of valinomycin, a potassium ionophore, known to
induce cytotoxic effects in most mammalian cell types. Whereas no toxicity was observed after Cry1Ab treatment,
valinomycin induced a decrease in IPEC-J2 viability. This was confirmed by dynamic monitoring of cellular responses.
Additionally, two dimensional differential in-gel electrophoresis was performed. Only three proteins were differentially
expressed. The functions of these proteins were associated with responses to stress. The up-regulation of heat shock protein
Hsp70 was verified by Western blotting as well as by enzyme-linked immunosorbent assay and may be related to a
protective function. These findings suggest that the combination of in vitro testing and proteomic analysis may serve as a
promising tool for mechanism based safety assessment.
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Introduction
Microbial insecticides containing d-endotoxins (Cry proteins)
from Bacillus thuringiensis (Bt) have been used as an alternative to
conventional chemical pesticides in agriculture for almost 60 years
and recently as resource for insect-resistant genetically modified
(GM) plants [1]. Currently, more than 90% of the feedstuffs for
pigs contain genetic modified compounds [2] and the interest in
GM crops is continuously increased because of higher agronomic
productivity and more nutritious food without the use of pesticides.
Since the introduction of GM crops many feeding trials focussed
on issues related to consumer safety have been conducted in
various animal species. In the majority of these studies no adverse
effects have been detected. However, few studies found subtle
histopathological changes and signs of hepatorenal toxicity in rats
[3,4] and altered immune responses in mice [5], fish [6] and pigs
[7]. Thus, there is an on-going debate on the risk of GM
consumption and a demand for additional evidence of GM food
and feed safety [8–11].
Although in vitro testing of GM food and feed compounds is
considered to be helpful to complement safety assessment
programmes and has been encouraged by international scientific
committees [10], only few data are available from cell culture
experiments. The application of an in vitro cell culture system
especially for preliminary screening of GM food has many
advantages, e. g. sufficient results at low costs, high speed and
less animal use [12]. Because of minor complexity of such cellular
systems in comparison to the animal better conclusions can be
drawn concerning specific mechanism of action. Moreover,
mammalian cell cultures may allow scientists to reveal possible
unintended side effects of novel proteins on non-target species.
Thus, there is a growing interest in suitable in vitro screening
systems possibly reflecting in vivo toxicity of food ingredients.
Liver and kidney are considered as the two major target organs
of detoxification. Therefore cell cultures derived from these organs
are in the focus of risk assessment. For example, a slight but not
statistically significant increase of LDH release after 48 h exposure
to Cry1Ab was observed on bovine hepatocytes [13]. Moreover Bt
toxins have been tested on human embryonic kidney cells [14].
Time- and dose dependent effects of relatively high concentrations
of Cry1Ab on viability of HEK293 cells, respiration inhibition and
plasma membrane alterations, were detected. In addition, cell
cultures from the gastrointestinal tract (GIT) are of particular
interest in comprehensive risk assessment. Cell cultures of the
digestive system are clearly superior to the use of any other cell
types, because the GIT represents the first barrier for exogenous
food and the primary portal and absorption side. Notably, since
very low amounts of full-size and fragmented Cry1Ab protein have
been detected in the GIT digesta [15]) in the rumen [16,17] and in
the GIT of pigs [18], such intestinal cell culture systems are also in
the focus of GM safety research. From the results on brush-border
membrane vesicles (BBMVs) it was concluded, that Cry1Ab may
not impair the membrane integrity or permeability of mammalian
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intestinal epithelial cells [19]. In contrast, our previous results on
perfused rumen epithelial cells suggest that at sufficiently high
concentrations spontaneous insertion of Cry1Ab into the mem-
brane of these cells occurs [20]. Nevertheless, we found no adverse
effects on viability of cultured rumen epithelial cells [21].
Consequently, there is a need for additional data in comprehensive
risk assessment regarding Cry1Ab on suitable in vitro systems.
The aim of this study was to identify possible effects of Cry1Ab
on porcine intestinal cells. The used IPEC-J2 cell line is well
characterized [22] and represents a convenient intestinal func-
tional cell model [23], that reflects the in vivo situation as faithfully
as possible. A novel electronic cell sensor array technology, the
real-time cell analysis (RTCA) system was used for dynamic
monitoring of cellular events of Cry1Ab response. In addition,
different viability parameters as the ATP level, the WST-1
conversion, the release of lactate dehydrogenase (LDH) and the
transepithelial electrical resistance (TEER) were used to get a
comprehensive data set to complete the understanding whether
Cry1Ab affects the viability of gastrointestinal cells. Furthermore,
the two dimensional differential in gel electrophoresis (2D-DIGE)
combined with mass spectrometry was employed to supplement
the viability approaches to better characterize the possible
interactions of Cry1Ab at the molecular and cellular levels. The
identified changes of Hsp70 level caused by Cry1Ab treatment
were further verified by Western blotting and enzyme-linked
immunosorbent assay (ELISA) using specific antibodies.
Materials and Methods
Cell Culture
The IPEC-J2 cell line is a non-transformed intestinal cell line
originally derived from jejunal epithelia, isolated from a neonatal,
unsuckled piglet [22]. Cells were grown in Dulbecco’s modified
eagle medium (DMEM)/Ham’s F-12 (1:1) supplemented with
10% fetal calf serum (Biochrom, Germany) and maintained in an
athmosphere of 5% CO2. For viability measurements IPEC-J2
cells were plated at 0.56104 cells per well in 96-well plates, for Hsp
detection cells were seeded at 0.56104 cells per well in 24-well
plates. After 24 h subconfluent cells were exposed to different
Cry1Ab concentrations for indicated time intervals. As a control,
cells were kept under same conditions without Cry1Ab. For
proteomic profiling IPEC-J2 cells of different passages (35–40)
were grown in 75 cm2 flasks. After reaching 80% confluence, the
cells were washed and the medium was replaced. The cells were
exposed to 1 mg/ml Cry1Ab for 24 h. For the control cells, the
medium without Cry1Ab was used.
Purification of Cry1Ab Protein
Cry1Ab was derived from the BMBF project 01K0-31P2614,
Germany. The protoxin Cry1Ab was prepared with a standardised
procedure from E. coli HB101/pMP as described by Nguyen [24].
Protoxins were activated by trypsinization and further purified,
yielding a toxin comprising a primary structure similar to toxins
present in transgenic plants. Size and purity were confirmed by
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) [24]. Finally, Cry1Ab was stored in 0.5 mM CAPS buffer
(pH 10.5). The toxicity was determined by a bioassay on
susceptible Ostrinia nubilalis larvae and the LC50 value (toxin
concentration at which 50% of the test animals die) was 50 ng/
cm2 for surface application [25]. The Cry1Ab toxin was stable in
our cell culture system for at least 48 hours, as tested by
immunoblotting using anti-Cry1Ab mouse monoclonal antibody
kindly provided by Dr. Wal (INRA, France).
Evaluation of Cell Viability
Cell proliferation was detected using the Cell Proliferation
Reagent WST-1 (Roche). The quantitation of ATP was used as a
further indicator of viable cells measured with CellTiter-Glo
Luminescent Cell Viability Assay (Promega). The released LDH
was determined using the CytoTox-ONETM Homogeneous
Membrane Integrity Assay (Promega), a fluorimetric method for
measuring the release of LDH from cells with damaged
membrane. These methods were performed according to the
manufacturer’s instructions and have been described in detail by
our group in a previous publication [21].
IPEC-J2 cells were treated for 24 h respectively for 48 h with
500 ng/ml and 1 mg/ml Cry1Ab. For all viability assays
valinomycin (500 ng/ml, ,0.556 mg/ml respectively) was used
as cell damaging control.
Real-time Cell Analysis
The xCELLigence system (Roche Applied Science and ACEA
Biosciences) was used to evaluate cell survival after Cry1Ab
treatment. The real-time cell analysis was performed under cell
culture conditions (37uC, 5% CO2, 95% humidity) on the E-plate
96 that differs from standard 96-well microtiter plates vastly with
its incorporated gold cell sensor arrays in the bottom. The
impedance of the sensor electrodes was measured to allow
monitoring the physiological behaviour of the cells on the
electrodes. In the presence of cells, cells attached to the electrode
sensor surfaces will lead to an increase in impedancehttp://www.
sciencedirect.com/science/article/pii/S0109564109002887 -
bbib30#bbib30. Thus, the Real-time xCelligence impedance
measurement correlates with changes in cell proliferation,
viability, and cytotoxicity. The xCELLigence system was used
according to the instructions of the supplier (Roche Applied
Science and ACEA Biosciences). First, the optimal seeding
concentration was determined. After seeding the respective
optimal number of cells (10,000/well) in 100 ml medium to the
wells of the E-plate 96, the physiological state of the IPEC-J2 cells
was monitored every 30 min by the xCELLigence system. After
4 h, when cells were in log growth phase, the IPECJ-2 cells were
exposed to 50 ml of medium containing 1 mg/ml Cry1Ab or
500 nM valinomycin, respectively. Controls received medium
only, or medium plus ethanol, respectively. Each experiment was
run for 24 h.
Transepithelial Electrical Resistance (TEER) Measurement
For TEER measurements, the cells were seeded on clear
polyester membrane cell culture inserts (SnapwellH, 12 mm
diameter, 1.12 cm2 area, 0.4 mm pore size; Corning B.V.,
Schiphol-Rijk, Netherlands) at a density of 105 cells/1.12 cm2
and were allowed to differentiate for 7–10 days. TEER
measurements were performed by using a Millicell-ERS (Electrical
Resistance System; Millipore GmbH, Schwalbach, Germany).
Cry1Ab was added when absolute TEER reached values at least
of 2500 V ? cm2 indicating a confluent monolayer [22,26].
Increasing doses of Cry1Ab (0.1, 0.5, 1 mg/ml) or valinomycin
(500 nM) were added at the apical side. The TEER was measured
after 24 and 48 h of treatment.
Two-dimensional Differential in Gel Electrophoresis (2-D
DIGE) Analysis
Extracts of total cell protein were prepared 24 h after exposure
to 1 mg/ml Cry1Ab. Cultured cells were washed twice with ice-
cold PBS, and lysed in lysis buffer (20 mM HEPES pH 7.8;
0.35 mM NaCl; 20% glycerol; 1% NP 40; 1 mM MgCl2; 1 mM
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dithiothreitol; 1 mM phenylmethylsulfonyl fluoride; 0.5 mM
EDTA; 0.5 mM EGTA; 0.5 mg/ml aprotinin and 1 mg/ml
leupeptin) for 30 min at 4uC. Cell lysates were centrifuged at
16,000 g for 5 min, and the supernatants were used for 2-D
DIGE.
For 2-D DIGE, a pool consisting of equal amounts of each cell
extract was prepared as an internal standard. Thus every protein
from every sample was represented in this standard on all gels.
This internal standard was always labeled with Cy2 and run
together with individual samples, from control and Cry1Ab
treated cells, labeled with other CyDyes (Cy3 or Cy5, GE
Healthcare). Each sample (60 mg) was labeled with 480 pmol
appropriate CyDye following the manufacturer’s protocol. The
total volume of each labeled protein sample (3660 mg) was
adjusted to 300 ml with DeStreak-TM Rehydration Solution (GE
Healthcare). Samples were applied to isoelectric focusing (IEF)
strips (3–10 pH range, nonlinear, 17 cm; BIO-RAD), which were
overlaid with 2.5 ml DryStrip Cover Fluid (GE Healthcare) and
equilibrated for 14 h at 50 V and isoelectrically focused at 1 h 200
V, 1 h 500 V, and finally at 10.000 V for 7 h by using a Protean
IEF cell (BIO-RAD). Thereafter, the strips were equilibrated for
15 min with gentle shaking in 50 mM Tris-HCl (pH 8.8)
containing 6 M urea, 4% SDS, 65 mM dithiotreitol (DTT),
30% glycerol, and 0.02% bromophenol blue; 135 mM iodoace-
tamide was added to the second equilibration solution instead of
DTT, and the strips were further incubated for 15 min in this
solution. Subsequently, strips were loaded onto 12% acrylamide
vertical gels. SDS-polyacrylamide gel electrophoresis (SDS–
PAGE) for the second dimension was carried out in an ETTAN
DALT six electrophoresis unit (GE Healthcare), first at 0.2 W per
gel for 1 h and thereafter at 2 W per gel for 18 h.
Image Acquisition and Analysis
Protein spots were visualized by using the Typhoon 9400 laser
imager (GE Healthcare) choosing the appropriate wavelength for
each Cy dye (Cy2= 520nm; Cy3= 580 nm; Cy5= 670 nm) at a
resolution of 100 mm, were cropped and imported into DeCyder
V.7.0 software (GE Healthcare). During spot detection by a co-
detection algorithm in the software, the estimated number of spots
were set at 2500, and the exclude filter was set a slope .1.7 and
area ,200. Only those proteins that appeared to be differentially
expressed in five gels were considered as differentially regulated.
The DeCyder differential in the gel analysis (DIA) modul was used
to process the images from a single gel and enables the pair-wise
comparison of each control and Cry1Ab-treated sample to the
pooled internal standard. The abundance of each protein spot was
determined as a ratio to its corresponding spot present in the
internal standard on the same gel. The DeCyder biological
variation analysis (BVA) module was used to standardize the ratios
across the gels accounting for the differences in the internal
standard.
Protein Identification via In-gel Digestion and Mass
Spectrometry
Changes of protein expression in response to Cry1Ab treatment
detected by 2-D DIGE analysis were matched with silver-stained
protein patterns (400 mg protein), and the three selected spots that
showed at least a 1.3-fold change in protein expression were
excised from the gel. Protein spots were in-gel digested by trypsin
(Promega, Germany) and proteins were further analyzed mass-
spectrometrically. A nanoLC-ESI-MS/MS analysis was per-
formed by Proteome Factory Berlin (Proteome Factory AG,
Germany) using an Agilent 1100 nanoLC system (Agilent,
Germany), PicoTip emitter (New Objective, USA) and an Esquire
3000 plus ion trap MS (Bruker, Germany). For protein identifi-
cation MS/MS ion search of Mascot search engine (Matrix
Science, England) and nr protein database (National Center for
Biotechnology Information, Bethesda, USA) were used. Ion
charge in search parameters for ions from ESI-MS/MS data
acquisition was set to ‘‘1+, 2+ or 3+’’ according to the instrument’s
and method’s common charge state distribution. Alternatively,
protein digests were analyzed by matrix-assisted laser desorption
ionization-time of flight mass spectrometry (MALDI-TOF-MS)
using an Ultraflex-II TOF/TOF instrument (Bruker Daltonics,
Bremen, Germany) equipped with a Smart beamTM laser. Peptide
mass fingerprints were recorded in the reflector mode using a-
cyano-4-hydroxycinnamic acid (CHCA) as the matrix.
Detection of Hsp70
Hsp70 concentration in IPEC-J2 extracts was quantified by an
ELISA (StressXpress Hsp70 ELISA; Stressgen Biotechnologies,
Victoria, BC, Canada) in accordance with the manufacturer’s
instructions. The Hsp70 values were normalized to the protein
concentration.
For Western blot analysis cells were lysed in RIPA buffer
containing a protease inhibitor mixture (Merck Biosciences).
Sample proteins (20 mg/lane) and a prestained protein-weight
marker (Bio-Rad Laboratories GmbH) were resolved by SDS-
PAGE (12% polyacrylamide gels) and transferred onto nitrocel-
lulose membranes in Tris-glycine buffer with 20% (v/v) methanol.
The membrane was saturated with 5% (w/v) non-fat milk powder
(Roth) prepared with phosphate-buffered saline containing 0,1%
Tween20 (PBST) for 1 h at room temperature, then incubated
with anti-Hsp70 mouse monoclonal antibody (Stressgen) overnight
at 4uC. After several washings with PBST the membranes were
incubated with a 1:20000 dilution of an anti-rabbit IgG
horseradish peroxidase-conjugated secondary antibody (GE
Healthcare). Bound antibodies were detected by using an
enhanced chemiluminescence system ECL Advance according to
the manufacturer’s instructions. Membranes were again incubated
with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mouse
monoclonal antibody (Abcam) to normalize the results. The
protein concentration of all extracts used in immunoassays was
determined with 2-D Quant Kit (GE Healthcare).
Results
IPEC-J2 Cell Responsiveness to Cry1Ab using Different
Parameters of Viability
By investigating different biochemical and physiological param-
eters of viability it was demonstrated that isolated Cry1Ab protein
does not influence the viability of porcine intestinal cells. Even
when using non-physiologically high concentrations of Cry1Ab
(500 ng/ml-1 mg/ml), no significant effects were found. LDH
release, WST-1 conversion, ATP content and TEER were used to
evaluate cytotoxicity of Cry1Ab, one of the expressed proteins in
transgene Bt-maize. The mitochondrial dehydrogenase activity
indicated by WST-1 conversion, as well as the ATP level reflecting
proliferation and metabolism were not significantly different to
untreated cells within 48 hours (Fig. 1A and 1B). Furthermore the
LDH-release, indicating membrane permeability alterations, was
not changed (Fig. 1C). The functional integrity of polarized IPEC-
J2 monolayers was assessed by TEER measurements. Figure 2
shows TEER determined at 2 different time points during 48 h of
Cry1Ab treatment. TEER was not significantly different between
the Cry1Ab treated cell monolayers and the controls. We applied
valinomycin as test control, as used in our previously published
experiments on rumen epithelial cells [21]. Valinomycin as
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potassium ionophore is known to induce permeability changes like
that of Cry1Ab in target cells [27]. Whereas no toxicity of Cry1Ab
was observed in our experiments, valinomycin causes a response of
all viability parameters (Fig. 1A–C). After 48 h the activity of
dehydrogenases decreased at 500 nM valinomycin by 63%,
accordingly the ATP content decreased by 47% and the LDH
release increased by 42%, revealing membrane alterations.
Real-time Monitoring of Cry1Ab Response
Furthermore, the real-time monitoring of nonconfluent IPEC-
J2 cells clearly indicates no toxic effect of Cry1Ab. Meanwhile
valinomycin leads to a short increase of the delta cell index which
later declines continuously below that of the control (Fig. 3). For
Cry1Ab treatment an increase of the delta cell index was observed
during the first hours after treatment. Thereafter it returns to the
Figure 1. Effect of Cry1Ab on viability of IPEC-J2 cells. IPEC-J2 cells were incubated with indicated concentrations of Cry1Ab for 24 h and 48 h,
respectively. Data are from one representative experiment out of 2 performed. (A) The Cell Proliferation Reagent WST-1 (Roche) was used to measure
mitochondrial dehydrogenase activity of viable cells. Valinomycin was used as cell damaging control. Bars represent the mean +/2S.D. of 5 replicate
wells. (B) The CellTiter-Glo Luminescent Cell Viability Assay (Promega) was used to estimate the number of viable metabolically active cells based on
quantitation of ATP. Bars represent the mean +/2S.D. of 5 replicate wells. (C) The CytoTox-ONETM Homogenous Membrane Integrity Assay (Promega)
was used for estimating the number of dead cells by release of LDH from damaged cells. Bars represent the mean +/2S.D. of 12 replicate wells.
doi:10.1371/journal.pone.0067079.g001
Impact of Cry1Ab on Porcine Intestinal Cells
PLOS ONE | www.plosone.org 4 July 2013 | Volume 8 | Issue 7 | e67079
baseline of the control cells (after 24 h) indicating a mild short
term and reversible effect of Cry1Ab.
Protein Expression Changes in Response to Cry1Ab
To analyze global protein expression changes induced by
Cry1Ab a quantitative proteome analysis of porcine intestinal cells
(IPEC-J2) was performed. After 24 h incubation with a non-
physiological high concentration of Cry1Ab (1 mg/ml) protein
Figure 2. Effect of Cry1Ab on transepithelial electrical resistance (TEER) in porcine intestinal epithelial monolayers. TEER of IPEC-J2
cell monolayers was measured 24 h and 48 h after application of increasing doses of Cry1Ab (0.1, 0.5, 1 mg/ml) or valinomycin (500 nM) at the apical
side [means 6 standard deviation; % of initial value t = 0 h]; n = 3 independent experiments (2–3 cell culture inserts per treatment group per
experiment).
doi:10.1371/journal.pone.0067079.g002
Figure 3. Dynamic monitoring of IPEC-J2 cell response after treatment with Cry1Ab and valinomycin using the xCELLigence
system. IPEC-J2 cells of 10,000 cells/well in E-plate96 were observed during 24 h. Data points represent mean values +/2 SEM (n= 5 wells).
doi:10.1371/journal.pone.0067079.g003
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extracts were prepared as described. Five biological replicates per
treatment were reverse labelled by Cy3 and Cy5 and run together
with the Cy2 labelled internal standard giving a total of 15 images.
Using DeCyder Software analysis about 2500 spots were detected
in each gel and quantified, normalized and inter-gel-matched..
Protein expression changes were considered as significant when
their quantity decreased or increased by at least 1.3-fold (student’s
T-test, p#0.05). Notably, Cry1Ab treatment caused only few
modifications in protein expression profiles, only three proteins out
of .2000 were differentially expressed (Table 1), one protein
(heat-shock protein 70) was more abundant and two proteins
(cytokeratin 8 and heterogeneous nuclear ribonucleoprotein) were
less abundant. The location of these spots is indicated in Figure 4
and the protein name, NCBI database accession number, Mascot
score and statistics for the three identified proteins are given in
Table 1.
To validate the DIGE/MS results the selected up-regulated
stress response biomarker Hsp70 was further quantified at the
protein level. The induction of Hsp70 was determined by ELISA
and verified by Western blotting (Fig. 5). Confirming the
proteomic profile, Fig. 5 indicates that Cry1Ab induces Hsp70
expression of porcine intestinal cells. Cultured IPEC–J2 cells
constitutively express Hsp70. Treatment of these cells with 1 mg/
ml Cry1Ab lead to induction of Hsp70 protein. As indicated in
Fig. 5 protein extracts from cells of 5 different passages were
analyzed by ELISA and show significant induction of Hsp70 (1.8-2
fold). The maximum level was reached within 24 h. Differences
between Hsp70 levels of Cry1Ab treated and non-treated control
cells were also confirmed by Western blotting (Fig. 5).
Discussion
The increasing presence of GM food and feed on the market
has provoked a strong demand for a comprehensive risk
assessment by use of 90-day rat feeding studies [28]. Alternative
in vitro cell culture assays may contribute to risk assessment yielding
supplementary information on cellular physiological and biochem-
ical mode of action of novel feed and food compounds.
In the present study we investigated whether Cry1Ab has any
effect on the viability of porcine intestinal cells (IPEC-J2). IPEC-J2
cells were selected for this study because this cell line maintains
differentiated characteristics and exhibits strong similarities to
primary intestinal epithelial cells [22]. Therefore it represents a
potentially more suitable model than most commonly used
transformed cell lines. It is also of note that this cell line may
represent an appropriate in vitro model with obvious homology to
humans for investigating gastro-intestinal reactions. Measurement
of multiple parameters of viability provides a better understanding
of the physiological state of the cells [12,21,29]. Therefore we
performed different endpoint assays. Particularly, the WST-1
conversion and the ATP content indicating the energy metabolism
and the LDH release reflecting the membrane integrity of the cells
were used in order to get a more comprehensive picture of the
impact of Cry1Ab on IPEC-J2 cells. Moreover, we used TEER as
functional parameter on differentiated IPEC-J2 cells grown on
collagen-coated membranes in order to characterize the barrier
function. Based on the results of these different parameters of cell
viability we were able to exclude a short-term toxic effect of
Cry1Ab on cultured IPEC-J2 cells.
Furthermore, we used the xCELLigence system for dynamic
monitoring of immediate cell response by use of cellular
impedance measurements [30,31]. Such real-time monitoring
allows label-free assessment of cell proliferation and enables
continuous information about any changes in morphology and
growth. Particularly, it is also advantageous that small and fast
changes can be detected using this method [32,33]. For validation
of real-time monitoring to measure cell fitness we used valinomy-
cin as apoptosis inducer [34], just as used for assay control in our
recent study on ruminal cells [21]. While for Cry1Ab a receptor
dependent specific toxicity to insect midgut epithelial cells is
discussed [35–39], it is generally accepted that valinomycin acts
independently of receptor(s) as a potassium ionophore leading to
ion leakage and inducing cytotoxic effects in vivo and in vitro [40–
42]. Therefore we used valinomycin as cell-damaging control and
could demonstrate that this K+ ionophore, in contrast to Cry1Ab,
exerts cytotoxic effects. The obvious changes in cell index are
consistent with reduction in cell viability and with the observed
decrease in TEER after 48 h. Consistent with the results of our
previous study [21]. The activity of the mitochondrial dehydro-
genases indicated by WST-1 conversion is the most sensitive
parameter of viability. However, regarding possible Cry1Ab
effects, no cytotoxic influence was found neither by the use of
the endpoint assays nor by real-time monitoring. Interestingly, we
observed a temporary increase in delta cell index of Cry1Ab
treated cells in comparison to control cells during the first 17
hours. This effect may be associated with stress induced
remodelling of cytoskeleton, a suggestion that is further supported
by our proteomic analysis. However, this effect was reversible and
for the precise interpretation of these real-time data further studies
should be performed by simultaneous monitoring of cellular
morphological changes.
In the present in vitro approach we have also included a
molecular proteomic profiling technique (2-DE) for Cry1Ab target
profiling and mechanism-based safety evaluation. Only few
proteins were found to be significantly modulated. The identified
proteins are multifunctional and involved in important cellular
processes as discussed in the following section.
Figure 4. Proteomic profiling of IPEC-J2 cells in response to
Cry1Ab treatment as revealed by 2D DIGE analysis. Image shows
one representative spot map of Cry1Ab treated IPEC-J2 cell extracts
(n = 5) indicating spot boundaries of proteins, whose expression level is
increased (red) or decreased (green) in comparison with the corre-
sponding untreated controls (only medium) (P,0.05) as revealed by
Decyder V.7.0 software. Spots marked with a number, correlating to the
identified proteins in Table1.
doi:10.1371/journal.pone.0067079.g004
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Heat shock proteins like Hsp70 are cellular chaperone proteins
that are required for essential cellular functions, such as, protein
folding and assembly or reassembly. Among the different families
of these proteins, the Hsp70-family consists of at least eight highly
homologous members (reviewed by Tavaria et al. [43] and
Daugaard et al. [44]). It has been reported, that the expression
of the two major members, the constitutive Hsp70c and the
inducible Hsp70 expression could be enhanced in response to
different stress conditions [45–47]. Previously these stress proteins
have been used to monitor the impact of environmental factors on
various animal species (reviewed by Mukhopadhyay et al. [48]),
including pig [49] as well as in in-vitro models [50]. Furthermore,
Hsp70 is known to inhibit the aggregation of nascent or misfolded
proteins to regulate protein degradation and to help in translo-
cation of proteins between different cellular compartments
(reviewed by Hartl et al. [51] and Arya et al. [52]). In addition
to its chaperoning function the Hsp70 protein family is required
for cell survival and therefore closely linked to cytoprotection by
conferring a protection of stressed cells. This may be related to the
ability of Hsp70 to prevent protein modifications [53], or it may be
explained by the ability of Hsp70 to inhibit stress-induced
apoptosis [54,55]. Furthermore it has been shown that the
induction of Hsps induced by either modest, physiologically
relevant increase in temperature or by glutamine supplementation
protects intestinal epithelial cells against injury and must not be
considered as adverse effect per se [50,56–57]. Hsp70 protects the
cells via multiple mechanisms, which include prevention of
caspase-dependent apoptosis in different cell types, including
intestinal cells [50,56–59]. In our earlier study, neither cytotoxic
effects nor signs of apoptosis could be detected in rumen epithelial
cells even at the same concentration of Cry1Ab [21]. Here we did
not test for apoptosis, but in the line with our previously published
paper we could not find any evidence for Cry1Ab mediated
cytotoxicity. Thus we can speculate, that the induction of Hsp70 in
Table 1. List of identified differentially expressed proteins in Cry1Ab treated IPEC-J2 cells.
Identified Protein No. pIa Mass (Da)a Score Accession no.b Average ratioc No. of matched Peptide (% PC)d
Heat shock 70 kD protein 1 5.8 71065 102 gi 178056524 +1.31 20 (36)
Keratin, type II, cytoskeletal 8 2 5.7 54394 236 gi 227430407 21.31 25 (48)
Heterologenous nuclear
ribonukleoprotein H2-like
3 6.1 49073 221 gi 335310367 21.37 23 (47)
a)Theoretical isoelectric point (pI).
b)Accession number in NCBI database.
c)Average ratio (Cry1Ab treated/non-treated control) indicates the value derived from the normalized spot volume standardized against the intra-gel standard provided
by DeCyder software analysis.
d)Peptide coverage, the amount of the identified proteins that the peptides covered.
doi:10.1371/journal.pone.0067079.t001
Figure 5. Increase of Hsp70 protein expression in Cry1Ab-treated IPEC-J2 cells. IPEC-J2 cells were treated with Cry1Ab for 24 hours and the
Hsp70 protein was determined by ELISA and Western blot (insert). For ELISA Hsp70 is normalized to mg protein extract used in the assay. The
normalized data are represented as mean relative to the control. Data represent the mean +/2 SD; n= 5 different experiments; (*) results are
significantly different as compared with untreated controls (P,0.05). For Western blotting the membranes were additionally incubated with
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mouse monoclonal antibody (Abcam), which serves as control for protein expression.
doi:10.1371/journal.pone.0067079.g005
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response to Cry1Ab in pig intestinal cells as found in our
proteomic analysis and further demonstrated by Western blotting
and ELISA may represent an adaptive response for the
maintaining of cellular homeostasis under stress. As further shown
by the proteomic profile in response to Cry1Ab IPEC-J2 cells
down-regulate cytokeratin 8 expression. The cellular consequences
of this altered cytokeratin expression are unknown. Interestingly
molecular chaperones perform cooperating roles in the regulation
of cytoskeleton function. It is known, that members of Hsp family
can interact with intermediate filaments and the cytoskeleton.
Particularly, Hsp70 immuno-precipitates with keratins 8 or 18
were found in several organs, including the digestive tract.
However, the nature of this relationship still remains uncertain
(reviewed by Liang and MacRae [60]. Generally, keratin functions
are facilitated by dynamic association with other proteins and by
posttranslational modifications like glycosylation [61]. The molec-
ular mechanisms governing keratin assembly or disassembly are
largely unknown [62] but several functions are discussed, including
protection of epithelial tissue from injury [63].
Furthermore, the heterogeneous nuclear ribonucleoprotein
(HnRNP) H2-like was differentially expressed under Cry1Ab
treatment. HnRNPs are a family of abundant nuclear proteins
with a wide range of molecular weights, which are believed to be
involved in pre-mRNA packaging and processing [64]. In fact,
these proteins have a variety of molecular partners (such as e.g.
Hsps) with multiple functions in signal transduction (reviewed by
Bomsztyk et al. [65] and [66], their special function in porcine
intestinal cells, however, remains speculative.
In summary, the present study shows that cultured porcine
gastrointestinal cells can tolerate Cry1Ab even in a dose range that
greatly exceeds any amount that may accumulate in the
gastrointestinal tract of pigs. No influence on viability of IPEC-
J2 cells was found using a screening with different assays including
real-time monitoring of cell viability. Nevertheless, consistent with
a previously published in vivo study in fish [6], our proteomic data
at 24 h were indicative of a mild stress response to Cry1Ab.
Further studies, particularly long-term investigations are needed to
determine whether increased Hsp70 expression is only a transient
short-term adaptive response to Cry1Ab or may be the cause of
further unintended side effects of this protein.
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